Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
5.63
-0.12 (-2.01%)
At close: May 9, 2025, 4:00 PM
5.63
0.00 (0.00%)
After-hours: May 9, 2025, 8:00 PM EDT

Serina Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
4.273.677.620.530.31
Short-Term Investments
----1
Cash & Short-Term Investments
4.273.677.620.531.31
Cash Growth
-50.99%-51.80%1331.53%-59.41%-
Receivables
----0
Prepaid Expenses
1.491.93-0.020.02
Other Current Assets
-0.08---
Total Current Assets
5.755.687.620.551.33
Property, Plant & Equipment
0.981.051.350.310.51
Total Assets
6.736.728.970.861.84
Accounts Payable
1.190.740.580.140.15
Accrued Expenses
0.981.430.580.010.01
Current Portion of Leases
-0.190.250.130.21
Current Unearned Revenue
---0.15-
Other Current Liabilities
0.19--0.010
Total Current Liabilities
2.352.371.410.440.37
Long-Term Debt
--2.981.62-
Long-Term Leases
0.230.270.460.060.19
Other Long-Term Liabilities
2.593.58-1.080.95
Total Liabilities
5.176.224.863.191.51
Common Stock
00-0.020.02
Additional Paid-In Capital
50.8344.960.880.650.64
Retained Earnings
-49.13-44.32-33.18-38.45-35.76
Total Common Equity
1.70.64-32.29-37.78-35.11
Minority Interest
-0.14-0.13---
Shareholders' Equity
1.560.514.11-2.340.33
Total Liabilities & Equity
6.736.728.970.861.84
Total Debt
0.230.463.71.810.4
Net Cash (Debt)
4.043.213.92-1.280.91
Net Cash Growth
--18.17%---
Net Cash Per Share
0.440.440.53-0.600.43
Filing Date Shares Outstanding
9.979.938.792.222.14
Total Common Shares Outstanding
9.939.422.472.222.14
Working Capital
3.43.316.210.110.96
Book Value Per Share
0.170.07-13.09-17.03-16.37
Tangible Book Value
1.70.64-32.29-37.78-35.11
Tangible Book Value Per Share
0.170.07-13.09-17.03-16.37
Machinery
-0.970.870.380.37
Updated Mar 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q